National Wealth Management Group LLC acquired a new stake in Colgate-Palmolive (NYSE:CL – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 3,676 shares of the company’s stock, valued at approximately $382,000.
Other institutional investors have also bought and sold shares of the company. B. Riley Wealth Advisors Inc. boosted its holdings in Colgate-Palmolive by 0.8% during the 1st quarter. B. Riley Wealth Advisors Inc. now owns 16,639 shares of the company’s stock valued at $1,498,000 after acquiring an additional 138 shares during the period. Hancock Whitney Corp increased its stake in Colgate-Palmolive by 1.3% during the 1st quarter. Hancock Whitney Corp now owns 12,017 shares of the company’s stock worth $1,082,000 after buying an additional 151 shares during the period. Citizens Financial Group Inc. RI lifted its holdings in Colgate-Palmolive by 12.4% during the 1st quarter. Citizens Financial Group Inc. RI now owns 14,082 shares of the company’s stock worth $1,268,000 after buying an additional 1,549 shares in the last quarter. LRI Investments LLC purchased a new position in Colgate-Palmolive in the 1st quarter valued at approximately $264,000. Finally, Atria Investments Inc increased its position in shares of Colgate-Palmolive by 3.2% during the first quarter. Atria Investments Inc now owns 67,625 shares of the company’s stock worth $6,090,000 after acquiring an additional 2,115 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.
Colgate-Palmolive Price Performance
CL stock opened at $96.75 on Thursday. The firm has a market cap of $79.05 billion, a P/E ratio of 27.72, a PEG ratio of 3.40 and a beta of 0.42. Colgate-Palmolive has a 1 year low of $75.50 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The stock’s 50 day moving average price is $97.61 and its 200 day moving average price is $98.58.
Colgate-Palmolive Dividend Announcement
Insiders Place Their Bets
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.37% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and upped their price target for the stock from $107.00 to $109.00 in a report on Monday, September 9th. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price objective for the company from $105.00 to $101.00 in a research report on Monday, October 28th. Piper Sandler started coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 price objective for the company. UBS Group increased their target price on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Finally, JPMorgan Chase & Co. upped their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus price target of $105.11.
View Our Latest Report on Colgate-Palmolive
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Short Selling: How to Short a Stock
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Technology Stocks Explained: Here’s What to Know About Tech
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
- Do ETFs Pay Dividends? What You Need to Know
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.